Berke Search
The Berke Report: Financing & Funds Updates for the First Week of May 2023
Morphic Therapeutic Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares (PR)...
top of page
bottom of page